These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23742971)

  • 1. For the special IJP issue "poorly soluble drugs".
    Loftsson T; Muellertz A; Siepmann J
    Int J Pharm; 2013 Aug; 453(1):1-2. PubMed ID: 23742971
    [No Abstract]   [Full Text] [Related]  

  • 2. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs.
    Perrie Y; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1517-8. PubMed ID: 21039536
    [No Abstract]   [Full Text] [Related]  

  • 3. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
    Müller CE
    Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanonization strategies for poorly water-soluble drugs.
    Chen H; Khemtong C; Yang X; Chang X; Gao J
    Drug Discov Today; 2011 Apr; 16(7-8):354-60. PubMed ID: 20206289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal excretion of water-soluble drugs].
    Ohsawa I; Tomino Y
    Nihon Jinzo Gakkai Shi; 2012; 54(7):977-80. PubMed ID: 23234207
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
    Kleberg K; Jacobsen J; Müllertz A
    J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
    Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
    Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
    Porter CJ; Wasan KM; Constantinides P
    Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
    Tiemessen H; van Hoogevest P; Leigh ML
    Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update.
    Yang M; Gong W; Wang Y; Shan L; Li Y; Gao C
    J Pharm Pharm Sci; 2016; 19(2):208-25. PubMed ID: 27518171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?
    Dalpiaz A; Pavan B; Ferretti V
    Drug Discov Today; 2017 Aug; 22(8):1134-1138. PubMed ID: 28130117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application research of hot-melt extrusion in preparation of solid dispersion].
    Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
    Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.